Notice of Application - 2010
[Federal Register: December 3, 2010 (Volume 75, Number 232)]
[Notices]
[Page 75496-75497]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03de10-76]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to
issuing a registration under this Section to a bulk manufacturer of a
controlled substance in schedule I or II, and prior to issuing a
regulation under 21 U.S.C. 952(a)(2) authorizing the importation of
such a substance, provide manufacturers holding registrations for the
bulk manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with 21 CFR 1301.34(a), this is notice
that on October 19, 2010, Tocris Cookson, Inc., 16144 Westwoods
Business Park, Ellisville, Missouri 63021-4500, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as an importer of the basic classes of controlled substances listed in
schedule I and II:
Drug |
Schedule |
Marijuana (7360) |
I |
Tetrahydrocannabinols (7370) |
I |
4-Bromo-2,5-dimethoxyamphetamine (7391) |
I |
3,4-Methylenedioxymethamphetamine (7405) |
I |
Amphetamine (1100) |
II |
Phencyclidine (7471) |
II |
Cocaine (9041) |
II |
Diprenorphine (9058) |
II |
Fentanyl (9801) |
II |
The company plans to import small quantities of the above-listed
controlled substances for distribution to its customers for non-
clinical, laboratory-based research only.
In reference to drug code 7360 (Marijuana), the company plans to
import synthetic cannabinoid agonists.
In reference to drug code 7370 (Tetrahydrocannabinols), the company
will import a synthetic Delta-9-THC. No other activity for these drug
codes are authorized for this registration.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic class of controlled
substance may file comments or objections to the issuance of the
proposed registration and may, at the same time, file a written request
for a hearing on such application pursuant to 21 CFR 1301.43, and in
such form as prescribed by 21 CFR 1316.47.
Any such comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than January 3, 2011.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975,
[[Page 75497]]
(40 FR 43745-46), all applicants for registration to import a basic
class of any controlled substance in schedule I or II are, and will
continue to be, required to demonstrate to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, that the requirements for such registration pursuant to
21 U.S.C 958(a); 21 USC 823(a); and 21 CFR 1301.34(b), (c), (d), (e),
and (f) are satisfied.
DATED: November 19, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-30338 Filed 12-2-10; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |